Viewing Study NCT04418167

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2026-01-31 @ 1:39 PM
Study NCT ID: NCT04418167
Status: SUSPENDED
Last Update Posted: 2025-09-03
First Post: 2020-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
Sponsor: JS InnoPharm, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None solid tumor View
None neoplasm View
None BRAF V600 mutation View
None MAPK pathway mutation View
None ERK1/2 View
None JSI-1187 View
None Dabrafenib View
None KRAS View
None NRAS View
None BRAF View
None melanoma View
None non-small cell lung cancer View
None anaplastic thyroid cancer View